홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Ammonium Chloride → N-(5-{[2-({[2-(hydroxymethyl)cyclopropyl]carbonyl}amino)imidazo[1,2-b]pyridazin-6-yl]oxy}-2-methylphenyl)-1,3-dimethyl-1H-pyrazole-5-carboxamide

HRID 2391425
인쇄

반응식

HRID 2391425 반응식
[Cl-].[Ca+2].[Cl-].[BH4-].[Na+].[CH3:6][N:7]1[C:11]([C:12]([NH:14][C:15]2[CH:16]=[C:17]([CH:38]=[CH:39][C:40]=2[CH3:41])[O:18][C:19]2[CH:20]=[CH:21][C:22]3[N:23]([CH:25]=[C:26]([NH:28][C:29]([CH:31]4[CH2:33][CH:32]4[C:34](OC)=[O:35])=[O:30])[N:27]=3)[N:24]=2)=[O:13])=[CH:10][C:9]([CH3:42])=[N:8]1.[Cl-].[NH4+]>O1CCCC1.C(O)C.C(OCC)(=O)C>[OH:35][CH2:34][CH:32]1[CH2:33][CH:31]1[C:29]([NH:28][C:26]1[N:27]=[C:22]2[CH:21]=[CH:20][C:19]([O:18][C:17]3[CH:38]=[CH:39][C:40]([CH3:41])=[C:15]([NH:14][C:12]([C:11]4[N:7]([CH3:6])[N:8]=[C:9]([CH3:42])[CH:10]=4)=[O:13])[CH:16]=3)=[N:24][N:23]2[CH:25]=1)=[O:30]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 4

HCID 25517Ammonium ChlorideHCID 4311764Sodium borohydrideHCID 5284359Calcium ChlorideHCID 57505658methyl 2-({[6-(3-{[(1,3-dimethyl-1H-pyrazol-5-yl)carbonyl]amino}-4-methylphenoxy)imidazo[1,2-b]pyridazin-2-yl]amino}carbonyl)cyclopropanecarboxylate

생성물 1

HCID 57505665
N-(5-{[2-({[2-(hydroxymethyl)cyclopropyl]carbonyl}amino)imidazo[1,2-b]pyridazin-6-yl]oxy}-2-methylphenyl)-1,3-dimethyl-1H-pyrazole-5-carboxamide
수율 20%

시약·촉매·용매 2

HCID 8857Ethyl Acetate용매HCID 21873804Tetrahydrofuran ethanol용매2회

실험 절차

To a suspension of calcium chloride (135 mg, 1.1 mmol) in tetrahydrofuran/ethanol (2/1, 1 mL) was added a solution of sodium borohydride (92 mg, 2.2 mmol) and methyl 2-({[6-(3-{[(1,3-dimethyl-1H-pyrazol-5-yl)carbonyl]amino}-4-methylphenoxy)imidazo[1,2-b]pyridazin-2-yl]amino}carbonyl)cyclopropanecarboxylate (180 mg, 0.37 mmol) in tetrahydrofuran/ethanol (2/1, 1 mL), and the mixture was stirred at room temperature for 18 hr. Saturated aqueous ammonium chloride solution and ethyl acetate were added to the reaction mixture, and the aqueous layer was extracted with ethyl acetate (×3). Combined organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and filtrated. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (ethyl acetate/hexane=40/60→100/0, and then methanol/ethyl acetate=0/100→5/95) to give the title compound (35 mg, 20%) as a white solid.

후처리

  1. extractionthe aqueous layer was extracted with ethyl acetate (×3)
  2. washCombined organic layer was washed with saturated brine
  3. dry with materialdried over anhydrous sodium sulfate
  4. filtrationfiltrated
  5. concentrationThe filtrate was concentrated under reduced pressure
  6. customthe residue was purified by silica gel column chromatography (ethyl acetate/hexane=40/60→100/0

출처 및 근거

ORD 기록
ord-0adeb9f7203d4ddca79052d67f2e354c
출처 데이터셋
uspto-grants-2012_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08273741B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트